Home » Zelnorm
Receive a free case review.
Zelnorm, also known as Tegaserod, is manufactured and marketed by
Novartis. The FDA approved Zelnorm to treat irritable bowel syndrome (IBS) in 2002 and chronic idiopathic constipation (CIC) in 2004. Zelnorm was extensively used in the United States with more than 500,000 prescribed users. Unfortunately, Zelnorm has been linked to severe cardiovascular side effects, including heart attacks and strokes. In March 2007, Novartis withdrew Zelnorm from the market.
What is Irritable Bowel Syndrome (IBS)?
Irritable bowel syndrome (IBS) involves a malfunction in the intestinal system. IBS is a functional disorder and not a disease. An estimated 12 million Americans (15% of the population) suffer from IBS. IBS symptoms include:
|
Related Topics: |
What is Chronic Idiopathic Constipation (CIC)?
Chronic idiopathic constipation (CIC) is the infrequent or difficult passage of stool for a three month period. In the United States, over 30 million adults develop CIC, requiring over 280,000 annual in-patient hospitalizations.
CIC symptoms include:
How does Zelnorm Work?
Scientists believe that serotonin is a key component to the human’s gastrointestinal function. Studies reveal that 95% of serotonin is found in the intestinal tract. Zelnorm causes nerve cells to imitate serotonin. The increased serotonin levels help a person expel stool. Zelnorm does not actually cure IBS or CIC. Rather, Zelnorm provides significant relief from IBS and CIC symptoms.
Zelnorm Side Effects
Zelnorm has been linked to several severe and even fatal side effects including:
Injured by Zelnorm?
If you or a loved one has been injured by Zelnorm, please contact our Zelnorm attorneys today for an assessment of your case.
Tegaserod